Company / Revenue per Share
Syndax Pharmaceuticals Inc Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$2.01
FY2025
5-year range
$0.00 / $2.01
FY2021-FY2025
Trend
+620.5%
vs FY2024
Sector context
#87 of 154
Health Care
What the data says
Revenue per Share changed +620% YoY in FY2025, a notable deviation from the 7-year average annual change of +65%.
Based on SEC 10-K filings.
2.01 in FY2025 with a 5-year CAGR of +104.7%.
Improved from $0.00 to $2.01 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +104.7%
- 10-Year CAGR
- -
Sector benchmark
#87 of 154 in Health CareTop 56% of 154This company $2.01 Sector average $15.09
▼
-86.7% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 620.5% year-over-year.
- Ranks #87 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2016.
- Lowest revenue per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.01 | +620.5% |
| FY2024 | $0.28 | - |
| FY2023 | $0.00 | - |
| FY2022 | $0.00 | -100.0% |
| FY2021 | $0.03 | -43.3% |
| FY2020 | $0.06 | -34.1% |
| FY2019 | $0.08 | +69.7% |
| FY2018 | $0.05 | +45.3% |
| FY2017 | $0.03 | -99.5% |
| FY2016 | $7.34 | -20.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026